The price of insulin is steep, but people who need it risk their health if they skip a dose. The Open Insulin Foundation aims to break the hold pharmaceutical companies exert on the cost, working instead with local labs to develop cheaper versions of insulin. We speak with co-founder Anthony Di Franco and Dr. Lisa Scheifele of the Baltimore Underground Science Space, BUGSS. Scheifele describes how e-coli cells are biohacked to create a fast-acting form of insulin.

Do you have a question or comment about a show or a story idea to pitch? Contact On the Record at: Senior Supervising Producer, Maureen Harvie she/her/hers [email protected] 410-235-1903 Senior Producer, Melissa Gerr she/her/hers [email protected] 410-235-1157 Producer Sam Bermas-Dawes he/him/his [email protected] 410-235-1472